ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $34,502,000 | -4.7% | 200,476 | -30.5% | 0.04% | 0.0% |
| Q2 2021 | $36,215,000 | -7.9% | 288,586 | -0.5% | 0.04% | -14.0% |
| Q1 2021 | $39,325,000 | +7.0% | 289,986 | +1.0% | 0.04% | +4.9% |
| Q4 2020 | $36,739,000 | +8.5% | 287,161 | -4.5% | 0.04% | 0.0% |
| Q3 2020 | $33,847,000 | +51.4% | 300,785 | +28.2% | 0.04% | +41.4% |
| Q2 2020 | $22,357,000 | +73.5% | 234,670 | +63.6% | 0.03% | +52.6% |
| Q1 2020 | $12,889,000 | +24.8% | 143,413 | -26.4% | 0.02% | +58.3% |
| Q4 2019 | $10,325,000 | +28.8% | 194,733 | -4.0% | 0.01% | +20.0% |
| Q3 2019 | $8,014,000 | +3.8% | 202,833 | +7.9% | 0.01% | 0.0% |
| Q2 2019 | $7,720,000 | -0.5% | 187,914 | +12.8% | 0.01% | 0.0% |
| Q1 2019 | $7,755,000 | +21.1% | 166,523 | +13.2% | 0.01% | +11.1% |
| Q4 2018 | $6,404,000 | -26.3% | 147,048 | -3.2% | 0.01% | -10.0% |
| Q3 2018 | $8,694,000 | +30.7% | 151,905 | +10.8% | 0.01% | +25.0% |
| Q2 2018 | $6,653,000 | +35.9% | 137,113 | +9.5% | 0.01% | +33.3% |
| Q1 2018 | $4,894,000 | -4.6% | 125,167 | +3.6% | 0.01% | 0.0% |
| Q4 2017 | $5,130,000 | +25.7% | 120,867 | +10.5% | 0.01% | +20.0% |
| Q3 2017 | $4,081,000 | +291.7% | 109,346 | +218.8% | 0.01% | +400.0% |
| Q2 2017 | $1,042,000 | +28.2% | 34,300 | +11.7% | 0.00% | 0.0% |
| Q1 2017 | $813,000 | +3.8% | 30,701 | +0.0% | 0.00% | 0.0% |
| Q4 2016 | $783,000 | -29.5% | 30,700 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $1,111,000 | +35.2% | 30,700 | +26.9% | 0.00% | +100.0% |
| Q2 2016 | $822,000 | +28.6% | 24,200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $639,000 | -40.4% | 24,200 | +10.0% | 0.00% | -50.0% |
| Q4 2015 | $1,073,000 | +107.1% | 22,000 | +5.8% | 0.00% | +100.0% |
| Q3 2015 | $518,000 | -20.1% | 20,800 | +1.5% | 0.00% | 0.0% |
| Q2 2015 | $648,000 | – | 20,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |